![Martine van Vugt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martine van Vugt
Directeur/Bestuurslid bij
MERUS N.V.
Profiel
Martine J.
van Vugt is currently Director at Hollandbio, Non-Executive Director at Merus NV starting in 2025, Chief Strategy Officer & Executive Vice President at Genmab A since 2023, and Member of the Supervisory Board at Flindr Therapeutics BV.
Former positions include Independent Director at Scandion Oncology A from 2022 to 2024 and Independent Member of the Supervisory Board at TME Pharma NV from 2021 to 2023.
Education includes a doctorate from the University of Utrecht and a graduate degree from Wageningen University.
Actieve functies van Martine van Vugt
| Bedrijven | Functie | Begin |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 29-03-2023 |
| MERUS N.V. | Directeur/Bestuurslid | 12-12-2025 |
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Directeur/Bestuurslid | - |
Hollandbio | Directeur/Bestuurslid | - |
Eerdere bekende functies van Martine van Vugt
| Bedrijven | Functie | Einde |
|---|---|---|
| SCANDION ONCOLOGY A/S | Directeur/Bestuurslid | 01-05-2024 |
| TME PHARMA N.V. | Directeur/Bestuurslid | 29-06-2023 |
Opleiding van Martine van Vugt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Wageningen University
 Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
Hollandbio | |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Health Technology |
